Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction TPF and Chemoradiation with Cetuximab/Cisplatin for Head and Neck Cancer
NCT00868491Phase 2Completed
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Mar 2008
- Primary completion
- Dec 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Institute of Oncology Ljubljana. Started Mar 2008; status: completed.
02
Drugs
KL-140
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00868491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868491.